Table: Daito - 9-MTH group results

Daito Pharmaceutical

12/04/2024 07:00

Apr 12 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 29, 2024        Feb 28, 2023     May 31, 2024 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               34.66               34.57            47.50    
                   (+0.3 pct)          (+2.9 pct)       (+5.3 pct)  
  Operating            3.11                4.11             4.80    
                   (-24.4 pct)         (-27.3 pct)      (-7.8 pct)  
  Recurring            3.12                4.08             4.80    
                   (-23.4 pct)         (-29.6 pct)      (-7.1 pct)  
  Net                  2.34                2.66             3.30    
                   (-12.1 pct)         (-33.1 pct)      (-8.3 pct)  
  EPS              148.35 yen          168.16 yen       208.82 yen  
  EPS Diluted                          167.96 yen                   
  Ann Div                               60.00 yen        60.00 yen  
  -Q2 div           30.00 yen           30.00 yen                   
  -Q4 div                               30.00 yen        30.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T